Jaguar Health, Inc. (NASDAQ:JAGX) | WebDisclosure

Basculer en Français

10812	Companies
234240	Keywords
163037	Articles
125255	Press releases

Home
Companies
Jaguar Health, Inc.

PRESS RELEASE

published on 06/23/2026 at 15:00, 1 month 14 days ago

Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Jaguar submits NADA for Canalevia-CA1 to FDA for CID in dogs, reporting positive results in study. Crofelemer effectively treats chemotherapy-induced diarrhea

Veterinary Medicine Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea NADA Submission
BRIEF

published on 06/22/2026 at 15:05, 1 month 15 days ago

Jaguar Health Explores Strategic Alternatives for Intestinal Failure Program

Crofelemer Biotechnology Strategic Alternatives Jaguar Health Intestinal Failure
BRIEF

published on 06/22/2026 at 15:05, 1 month 15 days ago

Jaguar Health explore des alternatives stratégiques pour son programme de prise en charge de l'insuffisance intestinale

Crofelemer Biotechnologie Jaguar Health Alternatives Stratégiques Insuffisance Intestinale
PRESS RELEASE

published on 06/22/2026 at 15:00, 1 month 15 days ago

Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program
Jaguar Health, Inc. to explore strategic alternatives maximizing stockholder value. Updates on crofelemer program for rare intestinal failure diseases by CEO Lisa Conte at Life Sciences Virtual Investor Forum on June 24, 2026

Crofelemer Strategic Alternatives Jaguar Health Lisa Conte Intestinal Failure Diseases
BRIEF

published on 06/18/2026 at 15:05, 1 month 19 days ago

Magdalena Biosciences dévoile des résultats précliniques prometteurs sur l'extrait de coca

Magdalena Biosciences Étude Préclinique Gestion De La Perte De Poids Extrait De Feuille De Coca Conseils Botaniques
BRIEF

published on 06/18/2026 at 15:05, 1 month 19 days ago

Magdalena Biosciences Unveils Promising Preclinical Study Results on Coca Extract

Magdalena Biosciences Preclinical Study Weight Loss Management Coca Leaf Extract Botanical Guidance
PRESS RELEASE

published on 06/18/2026 at 15:00, 1 month 19 days ago

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Announces Positive Results of Preclinical Study of Coca for Weight Gain Prevention
Magdalena's drug candidate, a coca leaf extract, shows promise for post-GLP-1 weight loss management. Preclinical study results suggest potential as weight maintenance therapy

Preclinical Study Magdalena GLP-1 Therapy Weight Loss Management Coca Leaf Extract
BRIEF

published on 06/12/2026 at 15:05, 1 month 25 days ago

Jaguar Health to Present at Life Sciences Virtual Investor Forum

Crofelemer Jaguar Health Intestinal Failure Life Sciences Forum Pediatric Studies
BRIEF

published on 06/12/2026 at 15:05, 1 month 25 days ago

Jaguar Health présentera ses services lors du Forum virtuel des investisseurs en sciences de la vie

Crofelemer Jaguar Health Insuffisance Intestinale Forum Des Sciences De La Vie Études Pédiatriques
PRESS RELEASE

published on 06/12/2026 at 15:00, 1 month 25 days ago

Jaguar Health Presenting June 24, 2026 at the Life Sciences Virtual Investor Forum to Provide Updates on Company's Crofelemer Development Program for Rare Intestinal Failure Diseases
Jaguar Health, Inc. announces virtual presentation by CEO Lisa Conte at Life Sciences Virtual Investor Forum on June 24, 2026. Crofelemer presentations at ESPGHAN Meeting

Virtual Presentation Jaguar Health Lisa Conte Life Sciences Forum ESPGHAN Meeting

Accesswire

Published on 08/08/2026 at 00:00, 8 hours 58 minutes ago

Boron One Announces Change of Auditor
Published on 08/07/2026 at 23:15, 9 hours 43 minutes ago

Faraday Copper Reports Second Quarter 2026 Financial Results
Published on 08/07/2026 at 23:00, 9 hours 58 minutes ago

Rio Grande Resources Announces up to $2,500,000 Non-Brokered Private Placement Financing
Published on 08/07/2026 at 22:30, 10 hours 28 minutes ago

UraniumX Deploys $3.8 Million to Athabasca Basin Exploration
Published on 08/07/2026 at 22:15, 10 hours 43 minutes ago

Noram Lithium Engages 1353656 BC Ltd. for Marketing and Management Consulting Services

View all ACCESSWIRE

EQS Group

Published on 08/07/2026 at 23:21, 9 hours 37 minutes ago

EQS-Adhoc: Northern Data Group reports Q2 2026 including the adverse fair value movement on contingent consideration
Published on 08/07/2026 at 19:30, 13 hours 28 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/07/2026 at 19:15, 13 hours 43 minutes ago

ABO Energy Agrees Sale of Its Polish and Hungarian Subsidiaries
Published on 08/07/2026 at 18:10, 14 hours 48 minutes ago

Stabilus SE: Andreas Jaeger steps down as Chief Financial Officer at his own request
Published on 08/07/2026 at 18:00, 14 hours 58 minutes ago

E-PANGO: Composition du capital au 31 juillet 2026

Les Echos

Published on 08/07/2026 at 18:54, 14 hours 4 minutes ago

Covivio - Déclaration des transactions sur actions propres réalisées du 03 août 2026 au 07 août 2026
Published on 08/07/2026 at 18:54, 14 hours 4 minutes ago

Covivio - Information on Treasury shares transactions between August 3rd, 2026, and August 7th, 2026
Published on 08/07/2026 at 18:40, 14 hours 17 minutes ago

Disclosure of transactions in own shares from August 3 to August 7, 2026
Published on 08/07/2026 at 18:40, 14 hours 17 minutes ago

Déclaration hebdomadaire d'opérations effectuées du 3 au 7 août 2026
Published on 08/07/2026 at 18:00, 14 hours 58 minutes ago

LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 juillet 2026

View all LES ECHOS COMFI WIRE